Vimentin Is an Attachment Receptor for Mycoplasma pneumoniae P1 Protein

Area of Science:

• Microbiology and Immunology
• Cell Biology
• Protein-Protein Interactions

Background:

• Mycoplasma pneumoniae is a common respiratory pathogen, with its P1 protein critical for infection.
• The precise mechanism of P1 protein adhesion to host cells remains incompletely understood.
• Identifying host cell receptors for M. pneumoniae P1 protein is crucial for understanding pathogenesis.

Purpose of the Study:

• To identify host cell proteins that specifically bind to the P1 protein of Mycoplasma pneumoniae.
• To elucidate the role of identified binding proteins in the adhesion process of M. pneumoniae.
• To explore potential therapeutic targets for Mycoplasma pneumoniae infections.

Main Methods:

• Screening for P1-binding proteins using a modified virus overlay protein binding assay (VOPBA) and liquid chromatography-mass spectrometry (LC-MS).
• Confirmation of interactions using far-Western blotting and coimmunoprecipitation assays.
• Functional validation through cell adhesion assays, adhesion inhibition assays, and gene silencing (siRNA) or overexpression of candidate receptors in BEAS-2B cells.

Main Results:

• Vimentin and β-4-tubulin were identified as potential binding partners for the P1 protein's carboxyl terminus (rP1-C).
• Vimentin, but not β-4-tubulin, was confirmed to interact with rP1-C and is localized on the cell membrane and cytoplasm of human bronchial epithelial cells (BEAS-2B).
• Adhesion of M. pneumoniae and rP1-C to BEAS-2B cells was significantly affected by vimentin expression levels, with inhibition observed using vimentin antibodies and decreased adhesion upon vimentin downregulation.

Conclusions:

• Vimentin acts as a functional receptor for the P1 protein on human bronchial epithelial cells.
• Vimentin plays a critical role in the adhesion of Mycoplasma pneumoniae to host cells.
• These findings provide a new perspective on the pathogenesis of M. pneumoniae and suggest vimentin as a potential target for therapeutic interventions.